Ex parte EPSTEIN et al. - Page 6




                 Appeal No. 96-2137                                                                                                                     
                 Application 07/668,920                                                                                                                 



























                 The three monoclonal antibodies identified by an asterisk in Table 1 are stated at page                                                
                 21 of the specification to be “[t]hree candidate antibodies.”  Furthermore, the                                                        
                 specification puts the data reported in Table 1 in perspective in the paragraph bridging                                               
                 pages 22-23 of the specification as follows:                                                                                           
                          In order to understand the significance of the data in Table 1, it is                                                         
                          important to realize that even a “live” in vitro culture will contain a                                                       
                          relatively large proportion of necrotic cells, as opposed to a population of                                                  
                          similar cells in vivo.  Thus, some binding to the “live” cell culture can be                                                  
                          expected, even with an antibody that is specific to only insoluble                                                            
                          intracellular antigen.  It should also be recognized that even though the                                                     
                                                                           6                                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007